You are here

Article Text

Article menu
Download PDFPDF
LETTER
Why do infants being treated for acute lymphoblastic leukaemia fail to thrive?
  1. E Ward1,
  2. S Kinsey2,
  3. M Richards2
  1. 1Dietetic Department, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK; paediatric_dietitian.sjuh@leedsth.nhs.uk
  2. 2Yorkshire Regional Centre for Paediatric Oncology & Haematology

https://doi.org/10.1136/adc.87.6.562

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Figure 1⇓ shows the weight gain of five infants treated for acute lymphoblastic leukaemia (ALL) in relation to centile chart positions, who were treated at the Yorkshire Regional Centre for Paediatric Oncology and Haematology from 1996 until the present. Patients 1–4 were treated in accordance with the MRC UKALL Infant 1 chemotherapy protocol,1 and patient 5 in accordance with Interfant 99.2

    The most striking aspect is that from diagnosis to end of intensive therapy …

    View Full Text